Janus Henderson Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $254M | Sell |
3,536,861
-80,085
| -2% | -$6.17M | 0.12% | 167 |
|
|
2025
Q4 | $287M | Buy |
3,616,946
+246,471
| +7% | +$19.4M | 0.13% | 159 |
|
|
2025
Q3 | $254M | Buy |
3,370,475
+354,812
| +12% | +$24.3M | 0.12% | 164 |
|
|
2025
Q2 | $208M | Buy |
3,015,663
+915,337
| +44% | +$60M | 0.1% | 184 |
|
|
2025
Q1 | $141M | Buy |
2,100,326
+1,335,140
| +174% | +$79.9M | 0.08% | 218 |
|
|
2024
Q4 | $34.4M | Buy |
765,186
+4,283
| +0.6% | +$240K | 0.02% | 468 |
|
|
2024
Q3 | $47.8M | Buy |
760,903
+599,200
| +371% | +$35M | 0.02% | 397 |
|
|
2024
Q2 | $9.56M | Sell |
161,703
-15,669
| -9% | -$980K | 0.01% | 678 |
|
|
2024
Q1 | $14.1M | Buy |
177,372
+4,318
| +2% | +$330K | 0.01% | 623 |
|
|
2023
Q4 | $13.7M | Sell |
173,054
-4,861
| -3% | -$346K | 0.01% | 613 |
|
|
2023
Q3 | $12.4M | Sell |
177,915
-42,430
| -19% | -$3.01M | 0.01% | 624 |
|
|
2023
Q2 | $15.2M | Buy |
220,345
+20,891
| +10% | +$1.49M | 0.01% | 604 |
|
|
2023
Q1 | $14.8M | Buy |
199,454
+2,302
| +1% | +$193K | 0.01% | 633 |
|
|
2022
Q4 | $18.4M | Sell |
197,152
-119,482
| -38% | -$11.5M | 0.01% | 586 |
|
|
2022
Q3 | $30.2M | Buy |
316,634
+145,993
| +86% | +$14.5M | 0.01% | 603 |
|
|
2022
Q2 | $15.8M | Sell |
170,641
-2,526,222
| -94% | -$247M | 0.01% | 606 |
|
|
2022
Q1 | $273M | Sell |
2,696,863
-548,607
| -17% | -$57.6M | 0.13% | 173 |
|
|
2021
Q4 | $335M | Sell |
3,245,470
-1,091,387
| -25% | -$101M | 0.14% | 166 |
|
|
2021
Q3 | $368M | Sell |
4,336,857
-446,598
| -9% | -$37.4M | 0.16% | 147 |
|
|
2021
Q2 | $399M | Buy |
4,783,455
+31,362
| +0.7% | +$2.57M | 0.17% | 139 |
|
|
2021
Q1 | $357M | Buy |
4,752,093
+1,124,402
| +31% | +$81.9M | 0.16% | 149 |
|
|
2020
Q4 | $248M | Buy |
3,627,691
+355,650
| +11% | +$23.1M | 0.12% | 190 |
|
|
2020
Q3 | $191M | Buy |
3,272,041
+1,256,506
| +62% | +$78.2M | 0.1% | 212 |
|
|
2020
Q2 | $131M | Buy |
2,015,535
+11,354
| +0.6% | +$715K | 0.07% | 262 |
|
|
2020
Q1 | $119M | Buy |
2,004,181
+811,572
| +68% | +$54.2M | 0.08% | 251 |
|
|
2019
Q4 | $88.6M | Buy |
1,192,609
+609,100
| +104% | +$42.8M | 0.05% | 414 |
|
|
2019
Q3 | $36.8M | Sell |
583,509
-27,905
| -5% | -$1.65M | 0.02% | 670 |
|
|
2019
Q2 | $33.3M | Sell |
611,414
-481,399
| -44% | -$25.9M | 0.02% | 683 |
|
|
2019
Q1 | $58.9M | Sell |
1,092,813
-513,344
| -32% | -$31.7M | 0.03% | 541 |
|
|
2018
Q4 | $105M | Buy |
1,606,157
+434,262
| +37% | +$32.4M | 0.07% | 333 |
|
|
2018
Q3 | $92.3M | Buy |
1,171,895
+555,880
| +90% | +$39.7M | 0.05% | 419 |
|
|
2018
Q2 | $39.6M | Sell |
616,015
-2,283
| -0.4% | -$150K | 0.02% | 619 |
|
|
2018
Q1 | $38.5M | Sell |
618,298
-246,615
| -29% | -$17.7M | 0.02% | 620 |
|
|
2017
Q4 | $62.7M | Sell |
864,913
-26,524
| -3% | -$1.93M | 0.04% | 485 |
|
|
2017
Q3 | $72.5M | Buy |
891,437
+159,671
| +22% | +$12.6M | 0.05% | 434 |
|
|
2017
Q2 | $58.9M | Buy |
731,766
+159,008
| +28% | +$12.6M | 0.04% | 475 |
|
|
2017
Q1 | $45M | Buy |
572,758
+36,842
| +7% | +$2.94M | 0.32% | 78 |
|
|
2016
Q4 | $42.3M | Sell |
535,916
-439,289
| -45% | -$35.5M | 0.31% | 80 |
|
|
2016
Q3 | $86.8M | Buy |
975,205
+17,254
| +2% | +$1.63M | 0.64% | 25 |
|
|
2016
Q2 | $91.7M | Buy |
957,951
+30,279
| +3% | +$3.02M | 0.76% | 19 |
|
|
2016
Q1 | $96.2M | Buy |
927,672
+37,172
| +4% | +$3.61M | 0.78% | 16 |
|
|
2015
Q4 | $87M | Sell |
890,500
-71,277
| -7% | -$6.98M | 0.7% | 20 |
|
|
2015
Q3 | $92.8M | Buy |
961,777
+271,110
| +39% | +$28.5M | 0.82% | 16 |
|
|
2015
Q2 | $72.4M | Sell |
690,667
-6,550
| -0.9% | -$669K | 0.57% | 29 |
|
|
2015
Q1 | $72M | Sell |
697,217
-40,508
| -5% | -$4.1M | 0.56% | 29 |
|
|
2014
Q4 | $71.1M | Buy |
737,725
+17,402
| +2% | +$1.53M | 0.51% | 37 |
|
|
2014
Q3 | $57.3M | Buy |
720,323
+234,467
| +48% | +$18.5M | 0.54% | 45 |
|
|
2014
Q2 | $36.6M | Sell |
485,856
-65,761
| -12% | -$4.97M | 0.34% | 69 |
|
|
2014
Q1 | $41.3M | Buy |
551,617
+140,599
| +34% | +$9.93M | 0.4% | 59 |
|
|
2013
Q4 | $29.4M | Buy |
411,018
+2,843
| +0.7% | +$183K | 0.3% | 84 |
|
|
2013
Q3 | $23.2M | Buy |
408,175
+30,084
| +8% | +$1.79M | 0.26% | 102 |
|
|
2013
Q2 | $21.8M | Buy |
+378,091
| New | +$21.9M | 0.25% | 107 |
|
Other funds holding CVS
VCM
VPM
Janus Henderson Group's CVS Position: Q1 2026 in Review
Janus Henderson Group reduced its CVS Health (CVS) stake by 2.2% in Q1 2026, selling an estimated $6.17M and leaving 3,536,861 shares worth $254M. The position accounts for 0.12% of the portfolio, ranked #167.
Janus Henderson Group first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $399M in Q2 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Janus Henderson Group held 3,536,861 shares of CVS Health worth $254M as of Q1 2026.
- Janus Henderson Group sold 80,085 CVS Health shares in Q1 2026, an estimated $6.17M.
- CVS Health made up 0.12% of Janus Henderson Group's portfolio in Q1 2026, its #167 holding.
- Janus Henderson Group first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Janus Henderson Group's CVS Health position peaked at $399M in Q2 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.